The FDA has approved a unique antidepressant – a skin patch. Emsam delivers a therapeutic dose through a patch applied externally once a day.

It’s one of a class of antidepressants called MAOI inhibitors (monoamine oxidase inhibitors) which have been used successfully for decades but require strict dietary restrictions, such as no cheese or chocolate, which some patients find difficult to follow. Because of this doctors have used MAOI inhibitors as a more “last resort” option.

The Emsam patch is a major improvement because its method of delivery through the skin means that at its lowest dose there are no dietary conflicts. (At higher doses, the same restrictions apply.)

Also, a once-a-day application means fewer doses for patients to forget, which would hopefully improve treatment adherence.

Read more.